So lets look at what product they used in this study
By targeting appetite regulation, glucose control, and energy balance, cagrilintide may represent an important step forward in managing obesity, type 2 diabetes, and related metabolic conditions ( 1, 3 )
If you develop a firm raised area at a previous injection site, avoid it and inform your prescriber at the next appointment
Case Study: James, 57-year-old with LADA, Obesity, CKD3a, CAD, and Dyslipidemia Clinical Snapshot: Patient Profile: A 57-year-old with LADA , obesity (BMI 38) , CKD3a (eGFR 48 mL/min/1.73 m) , CAD with stents , LV hypertrophy , EF 48% (on the HFrEF spectrum ), LDL 110 mg/dL , low HDL, high triglycerides
Clinical course The clinical course of APAP hepatotoxicity in patients with a single overdose can be classically divided into 4 sequential stages (table below ), however, it should be noted that the course is variable and may not follow the four-stage sequential pattern seen after a single oral ingestion